{
    "title": "Novartis results top forecasts as new products gain momentum",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2810684/Novartis-results-forecasts-new-products-gain-momentum.html",
    "date": "2014-10-28",
    "keywords": [
        "percent",
        "core",
        "year",
        "novartis",
        "competition",
        "pill",
        "growth",
        "quarter",
        "company",
        "health",
        "business",
        "unit",
        "momentum",
        "october",
        "gmt",
        "drug",
        "copycat",
        "blood",
        "pressure",
        "cancer",
        "lcz696",
        "track",
        "eye",
        "care",
        "sale",
        "digit",
        "rate",
        "email",
        "caroline",
        "copleyzurich",
        "drugmaker",
        "ag",
        "tuesday",
        "glivec",
        "bestselling",
        "diovanthe",
        "firm",
        "middle",
        "portfolio",
        "revamp",
        "series",
        "patent",
        "sclerosis",
        "gilenya",
        "tasigna",
        "afinitor",
        "acceleration",
        "quartergroup",
        "yearonyear",
        "share",
        "measure",
        "poll",
        "chief",
        "executive",
        "joe",
        "jimenez",
        "oct",
        "stock",
        "rise",
        "healthcare",
        "impact",
        "line",
        "heart",
        "multibillion",
        "dollar",
        "productjimenez",
        "approval",
        "december",
        "decision",
        "end",
        "tracknovartis",
        "april",
        "animal",
        "highermargin",
        "glaxosmithkline",
        "plc",
        "bit",
        "overhaul",
        "vaccine",
        "ltd",
        "revenue",
        "alcon",
        "sandoz",
        "division",
        "hit",
        "diovan",
        "version",
        "july",
        "beat",
        "billionjimenez",
        "deal",
        "half",
        "overthecounter",
        "marketthirdquarter",
        "profit",
        "gain",
        "shareholding",
        "idenix",
        "merck",
        "co"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}